Vimarsana
Biggest News Aggregation in the World

Page 14 - Sight Sciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sight Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sight Sciences Inc Today - Breaking & Trending Today

Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Advanced Health (NASDAQ:AHI), Aceragen (NASDAQ:ACGN) - Vimarsana News

Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Advanced Health (NASDAQ:AHI), Aceragen (NASDAQ:ACGN)

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.

Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA, a Randomized Controlled Clinical Trial Comparing Interventional Eyelid Procedures Enabled by TearCare® Technology to Restasis¹ for the Treatment of Dry Eye - Vimarsana News

Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA, a Randomized Controlled Clinical Trial Comparing Interventional Eyelid Procedures Enabled by TearCare® Technology to Restasis¹ for the Treatment of Dry Eye

MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...

Sight Sciences' TearCare Surpasses Restasis Dry Eye Treatment, Trial Data shows - Sight Sciences (NASDAQ:SGHT) - Vimarsana News

Sight Sciences' TearCare Surpasses Restasis Dry Eye Treatment, Trial Data shows - Sight Sciences (NASDAQ:SGHT)

Sight Sciences Inc (NASDAQ: SGHT) released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis 

Sight Sciences to Report Second Quarter 2023 Financial Results on August 3, 2023 - Vimarsana News

Sight Sciences to Report Second Quarter 2023 Financial Results on August 3, 2023

MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...

Glaukos Poised To Surpass Expectations And Raise Outlook In Q2 FY23, Fueled By iStent And iAccess Launches: Analyst - Glaukos (NYSE:GKOS) - Vimarsana News

Glaukos Poised To Surpass Expectations And Raise Outlook In Q2 FY23, Fueled By iStent And iAccess Launches: Analyst - Glaukos (NYSE:GKOS)

Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside is expected from the accelerating iAccess and iPRIME launches.